GlassScriptPhysician profile
Scott J Howard
NPI 1124334859
$19,780.29
in general payments reported to CMS, 2019-2025
42 companies · $3,818 in 2025
The $3,818 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,675 · 2020: $2,015 · 2021: $2,584 · 2022: $2,895 · 2023: $3,030 · 2024: $2,762 · 2025: $3,818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,292 · Education: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,292.22 |
| Education | $318.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,571.95 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $3,598.00 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Actelion Pharmaceuticals US, INC. | $2,653.34 | 2019-2025 | Opsumit, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,426.30 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Insmed, INC. | $800.72 | 2019-2025 | Arikayce, Brinsupri |
| Merck Sharp & Dohme LLC | $767.97 | 2019-2025 | Winrevair, Zerbaxa, Recarbrio |
| United Therapeutics Corporation | $766.40 | 2019-2025 | Tyvaso, Tyvaso |
| Grifols USA, LLC | $571.96 | 2019-2025 | Prolastin-C Liquid |
| Genzyme Corporation | $558.74 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $465.25 | 2019-2025 | Dupixent |
| Mylan Specialty L.P. | $376.54 | 2019-2024 | Yupelri |
| Mallinckrodt Hospital Products INC. | $300.31 | 2021-2025 | Acthar |
| Genentech USA, INC. | $296.40 | 2019-2023 | Xolair |
| Janssen Pharmaceuticals, INC | $278.45 | 2019-2024 | Xarelto |
| Baxter Healthcare | $261.22 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.